The negative immunoregulatory effects of fluoxetine in relation to the cAMP-dependent PKA pathway

International Immunopharmacology

Volumn 5, Issue 3, 2005, Pages 609-618

  Maes, Michael ^a,b,c   Kenis, Gunter ^a   Kubera, Marta ^d   De Baets, Mark ^e   Steinbusch, Harry ^e   Bosmans, Eugene ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VANDERBILT UNIVERSITY   (United States)

^c Clinical Research Center for Mental Health of Antwerp   (Belgium)

^d INSTITUTE OF PHARMACOLOGY   (Poland)

^e MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Antidepressants; cAMP; Cytokines; Depression; Fluoxetine; PKA; Second messengers

Indexed keywords

8 BROMOADENOSINE 3',5' MONOPHOSPHOROTHIOATE; 9 (TETRAHYDRO 2 FURYL)ADENINE; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; FLUOXETINE; GAMMA INTERFERON; INTERLEUKIN 10; LYASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; ENZYME INHIBITION; FEMALE; HUMAN; IMMUNOREGULATION; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 15944377405     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2004.11.008     Document Type: Article

References (44)

1. A. Służewska, J.K. Rybakowski, M. Laciak, A. Mackiewicz, M. Sobieska, and K. Wiktorowicz Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine Ann. N. Y. Acad. Sci. 762 1995 474 476
2. U.H. Frommberger, J. Bauer, P. Haselbauer, A. Fraulin, D. Riemann, and M. Berger Interleukin-6 (IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission Eur. Arch. Psychiatry Clin. Neurosci. 247 1997 228 233
3. A. Seidel, V. Arolt, M. Hunstiger, L. Rink, A. Behnisch, and H. Kirchner Cytokine production and serum proteins in depression Scand. J. Immunol. 41 1995 534 538
4. M. Maes, J. Delange, R. Ranjan, H.Y. Meltzer, R. Desnyder, and W. Cooremans Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs Psychiatry Res. 66 1997 1 11
5. C. Song, and B.E. Leonard An acute phase protein response in the olfactory bulbectomized rat: effect of sertraline treatment Med. Sci. Res. 22 1994 313 314
6. A. Służewska, E. Nowakowska, K. Gryska, and A. Mackiewicz Haptoglobin levels in a chronic mild stress model of depression in rats before and after treatment Eur. Neuropharmacol. P-1-18 1994 302
7. S. Lanquillon, J.C. Krieg, U. Bening-Abu-Shach, and H. Vedder Cytokine production and treatment response in major depressive disorder Neuropsychopharmacology 22 2000 370 379
8. M. Kubera, V. Holan, A. Basta-Kaim, A. Roman, J. Borycz, and J. Shani Effect of desipramine on immunological parameters in mice, and their reversal by stress Int. J. Immunopharmacol. 20 1998 429 438
9. M. Kubera, M. Maes, V. Holan, A. Basta-Kaim, A. Roman, and J. Shani Prolonged desipramine treatment increases the production of interleukin-10, an antiinflammatory cytokine, in C57BL/6 mice subjected to chronic mild stress model of depression J. Affect. Disord. 63 2001 171 178
10. Z. Xia, J.W. DePierre, and L. Nassberger Tricyclic antidepressants inhibit IL-6, IL-1β and TNF-α release in human blood monocytes and IL-2 and interferon-γ in T cells Immunopharmacol. 34 1996 27 37
11. M. Maes, C. Song, A.-H. Lin, S. Bonaccorso, G. Kenis, and R. De Jongh Negative immunoregulatory effects of antidepressants: inhibition of interferon-γ and stimulation of interleukin-10 secretion Neuropsychopharmacology 20 1999 370 379
12. P.D. Katsikis, S.B. Cohen, M. Londei, and M. Feldmann Are CD4+ Th1 cells pro-inflammatory or anti-inflammatory? The ratio of IL-10 to IFN-gamma or IL-2 determines their function Int. Immunol. 7 1995 1287 1294
13. M. Kubera, A.H. Lin, G. Kenis, E. Bosmans, D. van Bockstaele, and M. Maes Anti-inflammatory effects of antidepressants through suppression of the interferon-gamma/interleukin-10 production ratio J. Clin. Psychopharmacol. 21 2001 199 206
14. T.M. Aune, K.M. McGrath, T. Sarry, M.P. Bombara, and K.A. Kelley Expression of 5HT1a receptors on activated human T cells J. Immunol. 151 1993 1175 1183
15. K. Hellstrand, and S. Hermodsson Serotonergic 5-HT1A receptors regulate a cell contract-mediated interaction between natural killer cells and monocytes Scand. J. Immunol. 37 1993 7 18
16. M.T. Aune, H.W. Golden, and K.M. McGrath Inhibitors of serotonin synthesis and antagonists of serotonin 1A receptors inhibit T lymphocyte function in vitro and cell-mediated immunity in vivo J. Immunol. 153 1994 489 498
17. D.W. Bonhaus, C. Bach, A. DeSouza, F.H. Salazar, B.D. Matsuoka, and P. Zuppan The pharmacology and distribution of human 5-hydroxytryptamine2B (5-HT2B) receptor gene products: comparison with 5-HT2A and 5-HT2C receptors Br. J. Pharmacol. 115 1995 622 628
18. R. Mössner, and K.P. Lesch Role of serotonin in the immune system and in neuroimmune interactions Brain Behav. Immun. 12 1998 249 271
19. N. Benbernou, S. Esnault, H.C.K. Shin, H. Fekkar, and M. Guenounou Differential regulation of IFN-γ, IL-10 and inducible nitric oxide synthase in human T cells by cyclic AMP-dependent signal transduction pathway Immunology 91 1997 361 368
20. C. Platzer, C. Meisel, K. Vogt, M. Platzer, and H.D. Volk Up-regulation of monocytic IL-10 by tumor necrosis factor-alpha and cAMP elevating drugs Int. Immunol. 7 1995 517 523
21. A. Eigler, V. Matschke, G. Hartmann, S. Erhardt, D. Boyle, and G.S. Firestein Suppression of TNF-alpha production in human mononuclear cells by an adenosine kinase inhibitor J. Leukoc. Biol. 68 2000 97 103
22. L.M. Zhang, M.R. Castresana, I.J. Shaker, M.L. Dalton, S.K. Leeper-Woodford, and W.H Newman Increased intracellular cyclic adenosine 3′, 5′-monophosphate inhibits release of tumor necrosis factor-alpha from human vascular tissue and cultured smooth muscle cells Crit. Care Med. 25 1997 1855 1861
23. American Psychiatric Association Diagnostic and statistical manual of mental disorders 4th edition 1994 American Psychiatric Association Washington, DC
24. D. De Groote, P.F. Zangerle, Y. Gevaert, M.F. Fassotte, Y. Beguin, and F. Noizat-Pirenne Direct stimulation of cytokines (IL-1β, TNF-α, IL-6, IL-2, IFN-γ and GM-CSF) in whole blood. I: comparison with isolated PBMC stimulation Cytokine 4 1992 239 248
25. C.M. Doolan, S.B. Condliffe, and B.J. Harvey Rapid non-genomic activation of cytosolic cyclic AMP-dependent protein kinase activity and [Ca(2+)] by 17beta-oestradiol in female rat distal colon Br. J. Pharmacol. 129 2000 1375 1386
26. B.T. Gjertsen, G. Mellgren, A. Otten, E. Maronde, H.G. Genieser, and B. Jastorff Novel (Rp)-cAMPS analogs as tools for inhibition of cAMP-kinase in cell culture. Basal cAMP-kinase activity modulates interleukin-1 beta action J. Biol. Chem. 270 1995 20599 20607
27. M.A. Choudhry, Z. Ahmed, and M.M. Sayeed PGE(2)-mediated inhibition of T cell p59(fyn) is independent of cAMP Am. J. Physiol. 277 2 Pt 1 1999 C302 C309
28. M. Barcova, C. Speth, L. Kacani, F. Uberall, H. Stoiber, and M.P. Dierich Involvement of adenylate cyclase and p70(S6)-kinase activation in IL-10 up-regulation in human monocytes by gp41 envelope protein of human immunodeficiency virus type 1 Pflugers Arch. 437 1999 538 546
29. E.M. Aandahl, P. Aukrust, F. Muller, V. Hansson, K. Tasken, and S.S. Froland Additive effects of IL-2 and protein kinase A type I antagonist on function of T cells from HIV-infected patients on HAART AIDS 13 1999 F109 F114
30. P. Aukrust, E.M. Aandahl, B.S. Skalhegg, I. Nordoy, V. Hansson, and K. Tasken Increased activation of protein kinase A type I contributes to the T cell deficiency in common variable immunodeficiency J. Immunol. 162 1999 1178 1185
31. G. Kenis., M. Kubera., E. Bosmans., B. Egyed., M. De Baets, H. Steinbusch., M. Maes. Role of the cAMP/PKA-pathway in the anti-inflammatory effects of paroxetine and imipramine in diluted human whole blood. European Neuropsychopharmacology [in press].
32. M. Maes, C. Song, A. Lin, R. de Jongh, A. Van Gastel, and G. Kenis The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety Cytokine 10 1998 313 318
33. J.M. Cavaillon Interleukin-6 J.M. Cavaillon Les cytokines 1996 Masson Paris 184 199
34. M. Kubera, G. Kenis, E. Bosmans, M. Kajta, A. Basta-Kaim, and S. Scharpe Stimulatory effect of antidepressants on the production of IL-6 Int. Immunopharmacol. 4/2 2004 185 192
35. S.W. Kim, S.Y. Park, and O. Hwang Up-regulation of tryptophan hydroxylase expression and serotonin synthesis by sertraline Mol. Pharmacol. 61 2002 778 785
36. E. Arzt, M. Costas, S. Finkielman, and V.E. Nahmod Serotonin inhibition of tumor necrosis factor-alpha synthesis by human monocytes Life Sci. 48 1991 2557 2562
37. K. Hellstrand, C. Czerkinsky, A. Ricksten, B. Jansson, A. Asea, and H. Kylefjord Role of serotonin in the regulation of interferon-gamma production by human natural killer cells J. Interfer. Res. 13 1993 33 38
38. I. Cloez-Tayarani, A.-F. Petit-Bertron, H.D. Venters, and J.-M. Cavaillon Differential effect of serotonin on cytokine production in lipopolysaccharide- stimulated human peripheral blood mononuclear cells: involvement of 5-hydroxytryptamine2A receptors Int. Immunol. 15 2003 233 240
39. M. Kubera, G. Kenis, E. Bosmans, S. Scharpe, and M. Maes Effects of serotonin and serotonergic agonists and antagonists on the production of interferon-γ and interleukin-10 Neuropsychopharmacology 23 2000 89 98
40. M. Kubera, M. Maes, Kim Y-K, W. Lasoń. Effect of serotonin and serotonergic agonists and antagonists on the production of TNF-α and IL-6 in human whole blood. Psychiatry Res [in press].
41. J.M. Koch, S. Kell, and J.B. Aldenhoff Differential effects of fluoxetine and imipramine on the phosphorylation of the transcription factor CREB and cell-viability J. Psychiatr. Res. 37 2003 53 59
42. Y.H. Chong, Y.J. Shin, and Y.H. Suh Cyclic AMP inhibition of tumor necrosis factor alpha production induced by amyloidogenic C-terminal peptide of Alzheimer's amyloid precursor protein in macrophages: involvement of multiple intracellular pathways and cyclic AMP response element binding protein Mol. Pharmacol. 63 2003 690 698
43. T.K. Means, R.P. Pavlovich, D. Roca, M.W. Vermeulen, and M.J. Fenton Activation of TNF-alpha transcription utilizes distinct MAP kinase pathways in different macrophage populations J. Leukoc. Biol. 67 2000 885 893
44. S.R. Paludan, S. Ellermann-Eriksen, V. Kruys, and S.C. Mogensen Expression of TNF-alpha by herpes simplex virus-infected macrophages is regulated by a dual mechanism: transcriptional regulation by NF-kappa B and activating transcription factor 2/Jun and translational regulation through the AU-rich region of the 3′ untranslated region J. Immunol. 167 2001 2202 2208